Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CSPG4 fusions with interferon for the treatment of malignancy

Anti-CSPG4 fusions with interferon for the treatment of malignancy

US Patent 10822427 · Granted Nov 3, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for 2025
Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for 2025
Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for 2025
Fusion protein composition(s) comprising masked type i interferons (IFNA and IFN2024
Fusion protein composition(s) comprising masked type i interferons (IFNA and IFN2024
Fusion protein composition(s) comprising masked type I interferons (IFNA and IFN2023
Fusion protein composition(s) comprising masked type I interferons (IFNA and IFN2023
Fusion protein composition(s) comprising masked type I interferons (IFNA and IFN2021
Fusion protein composition(s) comprising masked type I interferons (IFNA and IFN2021
CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activitie2021
Targeted interferons demonstrate potent apoptotic and anti-tumor activities2019
Anti-CSPG4 fusions with interferon for the treatment of malignancy2018